[THE EFFECTIVENESS OF ERADICATION IN PATIENTS WITH PEPTIC ULCER DISEASE ASSOCIATED WITH HELICOBACTER PYLORI, DEPENDING ON THE GENOTYPE OF THE DRUGMETABOLISM OF PROTON PUMP INHIBITORS].

MLA

Elokhina, E. V., et al. “[The Effectiveness of Eradication in Patients with Peptic Ulcer Disease Associated with Helicobacter Pylori, Depending on the Genotype of the Drugmetabolism of Proton Pump Inhibitors].” Eksperimental’naia i Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology, no. 3, 2015, pp. 31–33. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=26281174&authtype=sso&custid=ns315887.

APA

Elokhina, E. V., Kostenko, M. B., Livzan, M. A., & Scalskiy, S. V. (2015). [The Effectiveness of Eradication in Patients with Peptic Ulcer Disease Associated with Helicobacter Pylori, Depending on the Genotype of the Drugmetabolism of Proton Pump Inhibitors]. Eksperimental’naia i Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology, 3, 31–33.

Chicago

Elokhina, E V, M B Kostenko, M A Livzan, and S V Scalskiy. 2015. “[The Effectiveness of Eradication in Patients with Peptic Ulcer Disease Associated with Helicobacter Pylori, Depending on the Genotype of the Drugmetabolism of Proton Pump Inhibitors].” Eksperimental’naia i Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology, no. 3: 31–33. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=26281174&authtype=sso&custid=ns315887.